BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 11422104)

  • 1. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement.
    White HD; Ahmad AM; Guzder R; Wallace AM; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):482-8. PubMed ID: 12641632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
    Bülow B; Erfurth EM
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which adults develop side-effects of growth hormone replacement?
    Holmes SJ; Shalet SM
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):143-9. PubMed ID: 7554308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the desire for long-term growth hormone replacement in adults.
    Holmes SJ; Shalet SM
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):151-7. PubMed ID: 7554309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low individualized growth hormone (GH) dose increased renal and cardiac growth in young adults with childhood onset GH deficiency.
    Link K; Bülow B; Westman K; Salmonsson EC; Eskilsson J; Erfurth EM
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):741-8. PubMed ID: 11895215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
    Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.